MD1407Z - Метод лечения наружных кишечных свищей - Google Patents
Метод лечения наружных кишечных свищей Download PDFInfo
- Publication number
- MD1407Z MD1407Z MDS20190059A MDS20190059A MD1407Z MD 1407 Z MD1407 Z MD 1407Z MD S20190059 A MDS20190059 A MD S20190059A MD S20190059 A MDS20190059 A MD S20190059A MD 1407 Z MD1407 Z MD 1407Z
- Authority
- MD
- Moldova
- Prior art keywords
- fistula
- blood
- treatment
- patient
- taken
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 43
- 208000008081 Intestinal Fistula Diseases 0.000 title claims abstract description 10
- 206010016717 Fistula Diseases 0.000 claims abstract description 37
- 230000003890 fistula Effects 0.000 claims abstract description 37
- 210000004369 blood Anatomy 0.000 claims abstract description 21
- 239000008280 blood Substances 0.000 claims abstract description 21
- 102000009123 Fibrin Human genes 0.000 claims abstract description 16
- 108010073385 Fibrin Proteins 0.000 claims abstract description 16
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229950003499 fibrin Drugs 0.000 claims abstract description 16
- 210000005087 mononuclear cell Anatomy 0.000 claims abstract description 11
- 210000004027 cell Anatomy 0.000 claims abstract description 8
- 239000000725 suspension Substances 0.000 claims abstract description 7
- 239000006285 cell suspension Substances 0.000 claims abstract description 6
- 210000003736 gastrointestinal content Anatomy 0.000 claims abstract description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 4
- 229960002897 heparin Drugs 0.000 claims abstract description 4
- 229920000669 heparin Polymers 0.000 claims abstract description 4
- 238000001356 surgical procedure Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 230000008569 process Effects 0.000 description 7
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 210000000813 small intestine Anatomy 0.000 description 6
- 208000006784 Cutaneous Fistula Diseases 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 238000011477 surgical intervention Methods 0.000 description 5
- 239000012190 activator Substances 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 210000003815 abdominal wall Anatomy 0.000 description 2
- 230000000123 anti-resoprtive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002350 laparotomy Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108010080865 Factor XII Proteins 0.000 description 1
- 102000000429 Factor XII Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- -1 TC 199 Substances 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000002938 Thrombospondin Human genes 0.000 description 1
- 108060008245 Thrombospondin Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000000515 collagen sponge Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000505 parietal peritoneum Anatomy 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000004862 vasculogenesis Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Изобретение относится к медицине, в частности к гнойной хирургии и может быть использовано для консервативного лечения наружных кишечных свищей.Сущность метода состоит в том, что за 24...48 часов до лечения у пациента проводят забор 20...40 мл крови, где добавляют 20…100 МЕ гепарина на 1 мл крови, отделяют суспензию мононуклеарных клеток, содержащей 3×107/мл клеток, также от пациента за 2...3 часа до первой процедуры проводят забор 40...60 мл крови, которую центрифугируют в течение 8...12 мин с 3000...3500 об./мин с получением фибринового сгустка обогащенного тромбоцитами, рану вокруг фистулы обрабатывают антисептическими растворами, аспирируют кишечное содержимое из фистулы, затем подкожно вокруг отверстия фистулы на расстоянии 1см от ее краев, вводят приготовленную суспензию мононуклеарных клеток в количестве 2...3 мл, после чего в канал свища вводят указанный фибриновый сгусток, процедуру повторяют через каждые 5 дней, а курс лечения включает 4...5 процедур.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190059A MD1407Z (ru) | 2019-06-17 | 2019-06-17 | Метод лечения наружных кишечных свищей |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190059A MD1407Z (ru) | 2019-06-17 | 2019-06-17 | Метод лечения наружных кишечных свищей |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1407Y MD1407Y (ru) | 2019-12-31 |
| MD1407Z true MD1407Z (ru) | 2020-09-30 |
Family
ID=69057883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20190059A MD1407Z (ru) | 2019-06-17 | 2019-06-17 | Метод лечения наружных кишечных свищей |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1407Z (ru) |
-
2019
- 2019-06-17 MD MDS20190059A patent/MD1407Z/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD1407Y (ru) | 2019-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12533398B2 (en) | Process, tube and device for the preparation of wound healant composition | |
| Thompson et al. | Use of lyophile plasma in correction of hypoproteinemia and prevention of wound disruption | |
| DK165169B (da) | Anvendelse af stoffer fra blodplader til fremstilling af topiske saarhelingsmidler | |
| US10456500B2 (en) | Implantable preparations for regeneration of tissues and treatment of wounds, their method of preparation, and method of treatment of patients with said implantable preparations | |
| Yan et al. | A novel thermosensitive growth-promoting collagen fibers composite hemostatic gel | |
| JPH02129224A (ja) | フィブリンの製造法 | |
| MD1407Z (ru) | Метод лечения наружных кишечных свищей | |
| RU2616239C2 (ru) | Способ лечения эрозивно-язвенных поражений кожи | |
| Albritton | Complications of wound repair | |
| Gambhir et al. | Next-generation bandages to overcome oxygen limitation during wound healing/tissue repair | |
| WO1999018931A1 (en) | Use of fibrin sealant to maintain hemostasis, lymphostasis and prevent local accumulation of body fluids | |
| MD1252Y (ru) | Метод лечения пупочной грыжи у пациентов с циррозом печени | |
| RU2847956C1 (ru) | Способ лечения инфицированных труднозаживающих ран с применением обогащённой тромбоцитами плазмы (PRP) | |
| RU2695706C1 (ru) | Способ лечения трофических язв при синдроме диабетической стопы | |
| MD1179Y (ru) | Метод лечения трофических язв | |
| CN116370690B (zh) | 胎盘底蜕膜复合制剂、其制法，含有其的医用敷料及应用 | |
| RU2777483C1 (ru) | Способ комбинированного лечения пролежней у пациентов в хроническом критическом состоянии | |
| RU2853744C1 (ru) | Способ профилактики раневых осложнений при герниопластике послеоперационных вентральных грыж | |
| RU2793743C1 (ru) | Способ лечения ран кожи и мягких тканей с помощью раневого покрытия на основе бактериальной целлюлозы | |
| MD1247Y (ru) | Метод лечения рецидивирующей гигантской паховой грыжи | |
| RU2421160C1 (ru) | Способ лечения гнойных ран мягких тканей | |
| Olsson et al. | Experience of extensive vascular surgery on defibrase-defibrinogenated patients | |
| Shehata et al. | Assessment of platelet rich plasma (PRP) therapy in prevention of chronic wound complications | |
| JPS62501628A (ja) | 創傷治癒剤 | |
| CN120168506A (zh) | 一种硫酸壳聚糖及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |